Trial Profile
Brexpiprazole for Bipolar Depression
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Brexpiprazole (Primary)
- Indications Bipolar depression; Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- 20 Apr 2018 Status changed from recruiting to completed.
- 12 Feb 2018 New trial record